Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07735741) titled 'Immune Dysregulation During Sepsis: A Natural History Cohort' on July 29.

Study Type: Observational

Primary Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Condition: Sepsis Septic Shock Sepsis-Associated Immune Dysregulation

Recruitment Status: Not recruiting

Date of First Enrollment: January 1, 2027

Target Sample Size: 500

Countries of Recruitment: United States

To know more, visit https://clinicaltrials.gov/study/NCT07735741

Published by HT Digital Content Services with permission from Health Daily Digest....